| Thyrotropin alfa |
EU/1/99/122/002 |
Thyrogen, Powder for solution for injection, 0.9 mg/ml - 1.2 ml, mg, Pack: 2 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom; Genzyme Ireland Ltd IDA Industrial Park Old Kilmeaden Road Waterford, Ireland |
1194.03 |
238.81 |
1432.84 |
4% |
10 |
1204.03 |
240.81 |
1444.84 |
16% |
25 |
1229.03 |
245.81 |
1474.84 |
Протокол 150/10.12.2015 |
НСР-7322/29.10.2015; НСР-9618/23.06.2016 г.; НСР-16202/19.07.2018 |
02.09.2018 |
02.09.2018 |
Заличен |
3494 |
| Thyrotropin alfa |
EU/1/99/122/002 |
Thyrogen, Powder for solution for injection, 0.9 mg/ml - 1.2 ml, mg, Pack: 2 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom; Genzyme Ireland Ltd IDA Industrial Park Old Kilmeaden Road Waterford, Ireland |
1194.03 |
238.81 |
1432.84 |
4% |
10 |
1204.03 |
240.81 |
1444.84 |
16% |
25 |
1229.03 |
245.81 |
1474.84 |
Протокол 150/10.12.2015 |
НСР-7322/29.10.2015; НСР-9618/23.06.2016 г. |
08.07.2016 |
02.08.2016 |
Неактивен |
3494 |
| Thyrotropin alfa |
EU/1/99/122/002 |
Thyrogen, Powder for solution for injection, 0.9 mg/ml - 1.2 ml, mg, Pack: 2 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom; Genzyme Ireland Ltd IDA Industrial Park Old Kilmeaden Road Waterford, Ireland |
1216.19 |
243.24 |
1459.43 |
4% |
10 |
1226.19 |
245.24 |
1471.43 |
16% |
25 |
1251.19 |
250.24 |
1501.43 |
Протокол 150/10.12.2015 |
НСР-7322/29.10.2015 |
14.11.2015 |
14.11.2015 |
Неактивен |
3494 |
| Thyrotropin alfa |
EU/1/99/122/002 |
Thyrogen, Powder for solution for injection, 0.9 mg/ml - 1.2 ml, mg, Pack: 2 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., UK |
1235.62 |
247.12 |
1482.74 |
4% |
10 |
1245.62 |
249.12 |
1494.74 |
16% |
25 |
1270.62 |
254.12 |
1524.74 |
промяна на обстоятелства НСР-5890/27.03.2015 |
НСР-5393/07.01.2015 |
21.01.2015 |
21.01.2015 |
Неактивен |
3494 |
| Thyrotropin alfa |
EU/1/99/122/002 |
Thyrogen, Powder for solution for injection, 0.9 mg/ml - 1.2 ml, mg, Pack: 2 |
Genzyme Europe B.V., Нидерландия |
Allston Landing, MA Protein Manufacturing, USA |
1252.96 |
250.59 |
1503.55 |
4% |
10 |
1262.96 |
252.59 |
1515.55 |
16% |
25 |
1287.96 |
257.59 |
1545.55 |
|
НСР-3531/16.05.2014 |
31.05.2014 |
31.05.2014 |
Неактивен |
3494 |
| Thyrotropin alfa |
EU/1/99/122/002 |
Thyrogen, Powder for solution for injection, 0.9 mg/ml - 1.2 ml, mg, Pack: 2 |
Genzyme Europe B.V., Нидерландия |
Allston Landing, MA Protein Manufacturing, USA |
1326.64 |
265.33 |
1591.97 |
4% |
10 |
1336.64 |
267.33 |
1603.97 |
16% |
25 |
1361.64 |
272.33 |
1633.97 |
|
КЦРР-214/27.02.2012 |
20.03.2012 |
20.03.2012 |
Неактивен |
3494 |
| Thyrotropin alfa |
EU/1/99/122/002 |
Thyrogen, Powder for solution for injection, 0.9 mg/ml - 1.2 ml, mg, Pack: 2 |
Genzyme Europe B.V., Нидерландия |
Allston Landing, MA Protein Manufacturing, USA |
1369.98 |
274 |
1643.98 |
6% |
15 |
1384.98 |
277 |
1661.98 |
18% |
30 |
1414.98 |
283 |
1697.98 |
|
КЦ-599/23.02.2009 |
12.03.2009 |
12.03.2009 |
Неактивен |
3494 |
| Thiamazole |
20080283 |
THYROZOL, Film coated tablet, 5, mg, Pack: 50 |
Мерк България ЕАД, България |
Merck KGaA, Merck KGaA&Co. Werk Spittal |
6.57 |
1.31 |
7.88 |
7% |
0.46 |
7.03 |
1.41 |
8.44 |
20% |
1.31 |
8.34 |
1.67 |
10.01 |
Промяна на обстоятелства НСР-20402/12.12.2019 |
НСР-2302/13.01.2014 |
30.01.2014 |
02.01.2020 |
Активен |
2415 |
| Thiamazole |
20080283 |
THYROZOL, Film coated tablet, 5, mg, Pack: 50 |
Merck KGaA, Германия |
Merck KGaA, Merck KGaA&Co. Werk Spittal |
6.57 |
1.31 |
7.88 |
7% |
0.46 |
7.03 |
1.41 |
8.44 |
20% |
1.31 |
8.34 |
1.67 |
10.01 |
|
НСР-2302/13.01.2014 |
30.01.2014 |
30.01.2014 |
Неактивен |
2415 |
| Thiamazole |
20080283 |
THYROZOL, Film coated tablet, 5, mg, Pack: 50 |
Merck KGaA, Германия |
Merck KGaA, Merck KGaA&Co. Werk Spittal |
7.49 |
1.5 |
8.99 |
7% |
0.52 |
8.01 |
1.6 |
9.61 |
20% |
1.5 |
9.51 |
1.9 |
11.41 |
|
КЦРР-2972/20.03.2013 |
06.05.2013 |
06.05.2013 |
Неактивен |
2415 |
| Thiamazole |
II-15202/12.12.2006 |
THYROZOL, Film coated tablet, 5, mg, Pack: 20 |
Merck KGaA, Германия |
Merck KGaA |
2.44 |
0.49 |
2.93 |
7% |
0.17 |
2.61 |
0.52 |
3.13 |
20% |
0.49 |
3.1 |
0.62 |
3.72 |
Цената се заличава с решение НСР-2668/03.02.2014 |
КЦ-680/06.03.2009 |
24.03.2009 |
24.03.2009 |
Заличен |
628 |
| Tianeptine |
20110644 |
Tialera, Film coated tablet, 12.5, mg, Pack: 30 |
Alvogen IPCo S.àr.l, Люксембург |
ZF Unia Poland; Jelfa SA Poland; Laboratorios Liconsa,S.A. Avenida Miralcampo,7 Poligono Industrial Miralcampo 19200 Azuqueca de Henares, Guadalajara Испания |
3.97 |
0.79 |
4.76 |
7% |
0.28 |
4.25 |
0.85 |
5.1 |
20% |
0.79 |
5.04 |
1.01 |
6.05 |
|
НСР-7757/28.12.2015; НСР-12386/18.04.2017; НСР-15252/15.03.2018 |
03.05.2017 |
02.04.2018 |
Заличен |
2159 |
| Tianeptine |
20110644 |
Tialera, Film coated tablet, 12.5, mg, Pack: 30 |
Alvogen IPCo S.àr.l, Люксембург |
ZF Unia Poland; Jelfa SA Poland; Laboratorios Liconsa,S.A. Avenida Miralcampo,7 Poligono Industrial Miralcampo 19200 Azuqueca de Henares, Guadalajara Испания |
3.97 |
0.79 |
4.76 |
7% |
0.28 |
4.25 |
0.85 |
5.1 |
20% |
0.79 |
5.04 |
1.01 |
6.05 |
|
НСР-7757/28.12.2015; НСР-12386/18.04.2017 |
03.05.2017 |
02.06.2017 |
Неактивен |
2159 |
| Tianeptine |
20110644 |
Tialera, Film coated tablet, 12.5, mg, Pack: 30 |
Alvogen IPCo S.àr.l, Люксембург |
ZF Unia Poland; Jelfa SA Poland; Laboratorios Liconsa,S.A. Avenida Miralcampo,7 Poligono Industrial Miralcampo 19200 Azuqueca de Henares, Guadalajara Испания |
6.51 |
1.3 |
7.81 |
7% |
0.46 |
6.97 |
1.39 |
8.36 |
20% |
1.3 |
8.27 |
1.65 |
9.92 |
|
НСР-7757/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
2159 |
| Tianeptine |
20110644 |
Tialera, Film coated tablet, 12.5, mg, Pack: 30 |
Alvogen IPCo S.àr.l, Люксембург |
ZF Unia Poland; Jelfa SA Poland; Laboratorios Liconsa,S.A. Avenida Miralcampo,7 Poligono Industrial Miralcampo 19200 Azuqueca de Henares, Guadalajara Испания |
6.75 |
1.35 |
8.1 |
7% |
0.47 |
7.22 |
1.44 |
8.66 |
20% |
1.35 |
8.57 |
1.71 |
10.28 |
|
НСР-1340/07.10.2013 |
23.10.2013 |
23.10.2013 |
Неактивен |
2159 |
| Tianeptine |
20110644 |
Tialera, Film coated tablet, 12.5, mg, Pack: 30 |
Alvogen IPCo S.àr.l, Люксембург |
ZF Unia Poland; Jelfa SA Poland; Laboratorios Liconsa,S.A. Avenida Miralcampo,7 Poligono Industrial Miralcampo 19200 Azuqueca de Henares, Guadalajara Испания |
6.85 |
1.37 |
8.22 |
7% |
0.48 |
7.33 |
1.47 |
8.8 |
20% |
1.37 |
8.7 |
1.74 |
10.44 |
промяна на обстоятелства решение КЦPP-1669/20.11.2012 |
КЦРР-851/15.06.2012 |
02.07.2012 |
02.07.2012 |
Неактивен |
2159 |
| Ticlopidine |
II-12591/13.03.2006 г. |
TICLOPID, Film coated tablet, 250 mg, mg, Pack: 20 |
Чайкафарма Висококачествените лекарства АД, България |
Чайка Фарма Висококачествените лекарства АД- Пловдив |
11.54 |
2.31 |
13.85 |
6% |
0.69 |
12.23 |
2.45 |
14.68 |
18% |
2.08 |
14.31 |
2.86 |
17.17 |
Цената се заличава с решение НСР-4620/15.09.2014 (в сила от 16.10.2014) |
КЦ-410/07.01.2009 |
03.02.2009 |
03.02.2009 |
Заличен |
427 |
| Imipenem, Cilastatin |
1963/21,04,2008 |
TIENAM, Powder for solution for infusion, 500 mg/ 500 mg, mg, Pack: 25 |
Мерк Шарп и Доум България ЕООД, България |
Merck Sharp & Dohme, CHIBRET , France; Merck Sharp & Dohme B.V.; The Netherlands |
476.85 |
95.37 |
572.22 |
4% |
10 |
486.85 |
97.37 |
584.22 |
16% |
25 |
511.85 |
102.37 |
614.22 |
|
КЦРР-2385/21.02.2013; НСР-11932/06.03.2017 |
18.03.2013 |
02.04.2017 |
Заличен |
1683 |
| Imipenem, Cilastatin |
1963/21,04,2008 |
TIENAM, Powder for solution for infusion, 500 mg/ 500 mg, mg, Pack: 25 |
Мерк Шарп и Доум България ЕООД, България |
Merck Sharp & Dohme, CHIBRET , France; Merck Sharp & Dohme B.V.; The Netherlands |
476.85 |
95.37 |
572.22 |
4% |
10 |
486.85 |
97.37 |
584.22 |
16% |
25 |
511.85 |
102.37 |
614.22 |
|
КЦРР-2385/21.02.2013 |
18.03.2013 |
18.03.2013 |
Неактивен |
1683 |
| Imipenem, Cilastatin |
1963/21,04,2008 |
TIENAM, Powder for solution for infusion, 500 mg/ 500 mg, mg, Pack: 25 |
Мерк Шарп и Доум България ЕООД, България |
Merck Sharp & Dohme, CHIBRET , France; Merck Sharp & Dohme B.V.; The Netherlands |
862.03 |
172.41 |
1034.44 |
4% |
10 |
872.03 |
174.41 |
1046.44 |
16% |
25 |
897.03 |
179.41 |
1076.44 |
|
КЦ-294/14.11.2008 |
04.12.2008 |
04.12.2008 |
Неактивен |
1683 |
| Venlafaxine |
20180035 |
Tifaxin MR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Hemopharm GmbH, Германия |
7.14 |
1.43 |
8.57 |
7% |
0.5 |
7.64 |
1.53 |
9.17 |
20% |
1.43 |
9.07 |
1.81 |
10.88 |
|
НСР-16955/12.10.2018 |
27.10.2018 |
02.11.2018 |
Активен |
16310 |
| Venlafaxine |
20090050 |
TIFAXIN SR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
STADA Arzneimittel AG, Германия; Dragenopharm Apotheker Pueschl GmbH, Германия; Generis Farmaceutica, S.A., Португалия; Centrafarm Services B.V., Нидерландия; Clonmel Healthcare Ltd, Ирландия; Eurogenerics N.V., Белгия; Genus Pharmaceuticals Ltd, Обединено кралство; PharmaCoDane ApS, Дания; STADA Arzneimittel GmbH, Австрия; Lamp San Prospero S.p.A., Италия; Delorbis Pharmaceuticals Ltd., Кипър |
7.63 |
1.53 |
9.16 |
7% |
0.53 |
8.16 |
1.63 |
9.79 |
20% |
1.53 |
9.69 |
1.94 |
11.63 |
промяна на обстоятелства НСР-10048/18.08.2016 |
НСР-5807/12.03.2015 |
26.03.2015 |
02.10.2016 |
Активен |
3682 |
| Venlafaxine |
20090050 |
TIFAXIN SR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
STADA Arzneimittel GmbH - Germany,Dragenopharm Apotheker Pueschl GmbH - Германия, Farma-APS Produtos Farmaceuticos, S.A. - Португалия, Centrafarm Services B.V. The Netherlands, Clonmel Healthcare Ltd - Ирландия, Eurogenerics NV - Belgium, Genus Pharmaceuticals Ltd - UK, PharmaCoDane ApS - Дания, STADA Arzneimittel GmbH - Австрия |
7.63 |
1.53 |
9.16 |
7% |
0.53 |
8.16 |
1.63 |
9.79 |
20% |
1.53 |
9.69 |
1.94 |
11.63 |
|
НСР-5807/12.03.2015 |
26.03.2015 |
26.03.2015 |
Неактивен |
3682 |
| Venlafaxine |
20090050 |
TIFAXIN SR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
STADA Arzneimittel GmbH - germany,Dragenopharm Apotheker Pueschl GmbH - Германия, Farma-APS Produtos Farmaceuticos, S.A. - Португалия, Centrafarm Services B.V. The Netherlands, Clonmel Healthcare Ltd - Ирландия, Eurogenerics NV - Belgium, Genus Pharmaceuticals Ltd - UK, PharmaCoDane ApS - Дания, STADA Arzneimittel GmbH - Австрия |
9.9 |
1.98 |
11.88 |
7% |
0.69 |
10.59 |
2.12 |
12.71 |
20% |
1.98 |
12.57 |
2.51 |
15.08 |
|
НСР-2322/13.01.2014 |
28.01.2014 |
28.01.2014 |
Неактивен |
3682 |
| Venlafaxine |
5712/08.09.2009 |
TIFAXIN SR, Prolonged release capsule, hard, 150, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
STADA Arzneimittel GmbH - germany,Dragenopharm Apotheker Pueschl GmbH - Германия, Farma-APS Produtos Farmaceuticos, S.A. - Португалия, Centrafarm Services B.V. The Netherlands, Clonmel Healthcare Ltd - Ирландия, Eurogenerics NV - Belgium, Genus Pharmaceuticals Ltd - UK, PharmaCoDane ApS - Дания, STADA Arzneimittel GmbH - Австрия |
19.56 |
3.91 |
23.47 |
6% |
1.17 |
20.73 |
4.15 |
24.88 |
18% |
3.52 |
24.25 |
4.85 |
29.1 |
Цената е вписана в регистъра на пределните цени с решение НСР-2568/24.01.2014 |
КЦ-1342/01.02.2010 |
22.02.2010 |
22.02.2010 |
Заличен |
889 |